Aprea Therapeutics, Inc. · NASDAQ:APRE
Stonepine Capital Management, LLC reported a 5.10% stake in Aprea Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Stonepine Capital Management, LLC reported a 5.10% stake in Aprea Therapeutics, Inc., 286,395 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 286,395
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Stonepine Capital Management, LLC | 5.10% | 286,395 |
| Stonepine Capital, L.P. | 5.10% | 286,395 |
| Stonepine GP, LLC | 5.10% | 286,395 |
| Jon M. Plexico | 5.10% | 286,395 |
Source
Related
- Aprea Therapeutics, Inc.
- Stonepine Capital Management, LLC
- Aprea Therapeutics, Inc. shareholders
- Schedule 13G/A · Stonepine Capital Management, LLC · May 14, 2025
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Form 4 · Grissinger Michael · Jun 17, 2026
- Form 4 · Gruia Gabriela · Jun 17, 2026
- Form 4 · Peters Richard · Jun 17, 2026
- Form 4 · Henneman John B III · Jun 17, 2026